New knee injection trial aims to ease arthritis pain
NCT ID NCT06606561
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new injection called NANOVAE for people with knee osteoarthritis. The treatment is made from human amniotic fluid and is given directly into the knee joint. The goal is to see if it is safe and can help reduce pain and improve function. The study will include 24 adults aged 21 to 75 with moderate knee osteoarthritis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bluetail Medical Group
Chesterfield, Missouri, 63005, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Carb diet ease knee pain? a study investigates racial differences
- Blocking knee blood vessels may offer new pain relief for severe osteoarthritis
- Which knee implant lasts longer? a Head-to-Head test
- Can cutting carbs curb knee pain? a diet trial puts it to the test
- Can virtual reality make knee pain therapy more engaging?
- Can a stem cell shot rebuild Worn-Out knees?